Controlling Cellular Machinery - Diagnostics and Therapeutics |
The summary for the Controlling Cellular Machinery - Diagnostics and Therapeutics Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.
-
Federal Grant Title: Controlling Cellular Machinery - Diagnostics and Therapeutics CFDA Number: 12.910 CFDA Description: Research and Technology Development Federal Agency Name: DARPA Defense Sciences Office Category of Funding Activity: Science and Technology Category Explanation: Information not provided Opportunity Category: Discretionary Funding Opportunity Number: DARPA-BAA-11-23 Document Type: Grants Notice Funding Instrument Type: Cooperative Agreement Procurement Contract Posted Date: Nov 29, 2010 Creation Date: Nov 29, 2010 Original Closing Date for Applications: Mar 03, 2011 Current Closing Date for Applications: Mar 03, 2011 Archive Date: May 03, 2011 Expected Number of Awards: Information not provided Estimated Total Program Funding: Information not provided Federal Grant Award Ceiling: Information not provided Federal Grant Award Floor: Information not provided Cost Sharing or Matching Requirement: No
- Applicants Eligible for this Grant
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
- Additional Information on Eligibility
- Information not provided
- Grant Description
- DARPA is soliciting research proposals for the development of synthetic regulatory genetic elements that can be used in mammalian cells. The proposed research should comprise approaches that enable fundamental advances to the development and broad application of synthetic regulatory elements for in vivo biomedical applications to detect, treat, or prevent disease. Technical challenges that need to be addressed include, but are not limited to, discovery, characterization, evolution or design, and demonstration of orthogonal and modular genetic regulatory elements; construct stability and function in the cell; and synthesis, amplification, and delivery of novel circuits in mammalian cells. The designed modules must limit specific interactions with the cellular metabolism or milieu to the desired performance characteristics and demonstrate maintenance of independent function without interference long enough to achieve the intended clinical effect. Specifically excluded is research that primarily results in evolutionary improvements to the existing state of practice. Proposers that intend to pursue nucleic acid vaccines as an application are referred to the companion announcement, Controlling Cellular Machinery - Vaccines, DARPA-BAA-11-22.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- Dr. Daniel Wattendorf
BAA Coordinator [DARPA-BAA-11-23@darpa.mil] - Similar Government Grants
- • Automated Program Analysis for Cybersecurity (APAC)
- • Social Media in Strategic Communication (SMISC)
- • Biochronicity
- • Build2011-3A-Synopsis01
- • Binary Executable Transforms (BET)
- • Wide Band Gap Semiconductors for RF Applications (WBGS-RF)
- • Robust Integrated Power Electronics (RIPE)
- • Microantenna Arrays:Technology and Applications (MIATA)
- • Imaging Coherent Optical Radar (ICHOR)
- • Terahertz Imaging Focal Plane Array Technology (TIFT)